The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease

K Seppi, D Weintraub, M Coelho… - Movement …, 2011 - Wiley Online Library
Abstract The Movement Disorder Society (MDS) Task Force on Evidence‐Based Medicine
(EBM) Review of Treatments for Parkinson's Disease (PD) was first published in 2002 and …

Parkinson's disease psychosis: presentation, diagnosis and management

RB Schneider, J Iourinets, IH Richard - Neurodegenerative …, 2017 - Taylor & Francis
Parkinson's disease is a neurodegenerative disorder characterized by motor and nonmotor
symptoms. Psychosis is a common feature of Parkinson's disease. Parkinson's disease …

[HTML][HTML] Parkinson's disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis

G DeMaagd, A Philip - Pharmacy and therapeutics, 2015 - ncbi.nlm.nih.gov
Parkinson’s Disease and Its Management - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search …

Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial

J Cummings, S Isaacson, R Mills, H Williams… - The Lancet, 2014 - thelancet.com
Background Parkinson's disease psychosis, which includes hallucinations and delusions, is
frequent and debilitating in people with Parkinson's disease. We aimed to assess safety and …

Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management

J O'Brien, JP Taylor, C Ballard, RA Barker… - Journal of Neurology …, 2020 - jnnp.bmj.com
Visual hallucinations are common in older people and are especially associated with
ophthalmological and neurological disorders, including dementia and Parkinson's disease …

The serotonergic system in Parkinson's disease

P Huot, SH Fox, JM Brotchie - Progress in neurobiology, 2011 - Elsevier
Although the cardinal manifestations of Parkinson's disease (PD) are attributed to a decline
in dopamine levels in the striatum, a breadth of non-motor features and treatment-related …

Psychosis in Parkinson's disease: epidemiology, pathophysiology, and management

A Chang, SH Fox - Drugs, 2016 - Springer
Psychotic symptoms are common in Parkinson's disease (PD) and are associated with
poorer quality of life and increased caregiver burden. PD psychosis is correlated with …

Treatment of psychosis and dementia in Parkinson's disease

JG Goldman, S Holden - Current treatment options in neurology, 2014 - Springer
Opinion statement Parkinson's disease (PD) has been increasingly recognized as having a
multitude of nonmotor symptoms including psychosis, cognitive impairment and dementia …

Comparative efficacy, safety, and acceptability of pimavanserin and other atypical antipsychotics for Parkinson's disease psychosis: systematic review and network …

I Yunusa, N Rashid, R Seyedin… - Journal of Geriatric …, 2023 - journals.sagepub.com
Background The current comparative efficacy, safety, and acceptability of atypical
antipsychotics (AAPs) in treating Parkinson's Disease Psychosis (PDP) are not entirely …

Parkinson disease and dementia

S Garcia-Ptacek… - Journal of geriatric …, 2016 - journals.sagepub.com
Dementia is a frequent complication of Parkinson disease (PD) with a yearly incidence of
around 10% of patients with PD. Lewy body pathology is the most important factor in the …